HWKN - Hawkins completes $5M capital investment in Minneapolis facility

Hawkins (HWKN) has announced that it has completed $5M capital investment in its Minneapolis, MN facility to drive further growth in its pharmaceutical ingredient business.The investment included automation capabilities and additional storage for raw materials and finished goods.“This expansion is consistent with our long-term growth strategy to make targeted investments in higher margin, faster growing markets. Will generate strong returns on these investments, especially given recent on-shoring trends, increased demands for these products, and overall growth in this industry.” stated Patrick Hawkins, President and CEO.

For further details see:

Hawkins completes $5M capital investment in Minneapolis facility